For a retrospective study involving 607 oncology patients treated from 2014-2019, the potential for predicting patient prognosis and guiding immunotherapy treatment through the analysis of total tumor volume (TTV) and artificial intelligence (AI) tumor heterogeneity from CT scans was investigated.
Read More
In early-stage non-small cell lung cancer (NSCLC), the recommended treatment options include targeted and immune therapies.
Read More![[18F] FDG-PET/CT Helps Predict PD-L1 Expression in eNSCLC](https://cdn.physiciansweekly.com/wp-content/uploads/2023/08/lung-cancer-e1708143543972-627x376.jpg)
In the management of early-stage non-small cell lung cancer (eNSCLC), the introduction of PD-1/PD-L1 checkpoint inhibitors has marked a significant advancement.
Read More
Cancer-associated fibroblasts (CAFs) constitute a critical element of the tumor microenvironment, and TGFβ-induced CAFs have been implicated in poor prognosis across various indications.
Read More
One of ESMO’s most popular track is its Young Oncologist Track designed and initiated by the ESMO Young Oncologist Committee.
Read More
There are more than 50 satellite symposia sessions taking place at ESMO. Follow PW for conference coverage.
Read More
Take a look at ESMO’s keynote sessions and full schedule. Follow PW for conference coverage.
Read More
Fall Clinical Dermatology Conference is providing a free live stream for some of the sessions. The live stream allows doctors who are not able to attend in person.
Read More
Find the list of Fall Clinical Dermatology Conference’s learning objectives, and follow along for PW coverage.
Read More
Take a look at the agenda for Fall Clinical Dermatology Conference. And follow along at PW for conference coverage.
Read More
A curated ebook on lung cancer biomarkers featuring recent studies, findings, and opinions from thought leaders.
Read More
Between 20% and 30% of patients with schizophrenia (SCZ)—and up to 50% patients with SCZ older than 50—develop tardive dyskinesia (TD), according to a study published in Genes & Genomics.
Read More
“When experts determine that high blood pressure, heart disease and diabetes are actually good for you, you’re going to feel awfully foolish!”
Read More
Physician’s Weekly recently spoke with Lin Chang, MD, AGAF, lead author of the 2022 AGA Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation (IBS-C).
Read More
“You can download an app for your phone that shows how many miles you didn’t walk today.”
Read More
“The handle of your recliner does not qualify as an exercise machine.”
Read More
Physician’s Weekly recently spoke with Brooks Cash, MD about NHE3 inhibitors and their unique method of action (MOA) in treating patients with IBS-C.
Read More
An uptick in biomarker testing for non-small cell lung cancer (NSCLC) over the past decade indicates an ongoing trend toward personalization of treatment choices.
Read More
A quiz based on the latest tardive dyskinesia news and studies.
Read More
“You went camping and a bear mistook your blood for honey. Would you mind if I order a diabetes test for you?”
Read More
